Christina K. Theodorou

FDA investigator

Appears on 19 documents from 2016 to 2026, mostly at sites in Pennsylvania. Most often cites responsibilities of quality control unit (21 CFR 211.22).

19
Documents on file
5.2
Observations per 483
2016
First seen
2026
Most recent

What they cite most

From 99 observations

Activity by year

2016: 1, 2017: 2, 2018: 1, 2019: 1, 2020: 3, 2022: 3, 2023: 2, 2024: 2, 2025: 3, 2026: 1

Where

Pennsylvania 14 · New Jersey 3 · Maryland 1 · Virginia 1

Is Christina K. Theodorou coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

19 documents, newest first
FirmOpen
483 Annovex Pharma, Inc.May 27, 2026 · Lorton, Virginia
483 Boothwyn Pharmacy LLCJun 9, 2025 · Kennett Square, Pennsylvania
483 US Specialty Formulations LLCMar 26, 2025 · Allentown, Pennsylvania
483 US Specialty Formulations LLCMar 26, 2025 · Allentown, Pennsylvania
483 Boothwyn Pharmacy LLCOct 22, 2024 · Kennett Square, Pennsylvania
483 Hikma Pharmaceuticals USA Inc.Jun 12, 2024 · Cherry Hill, New Jersey
483 Stokes Healthcare Inc . dba Epicur PharmaOct 25, 2023 · Mount Laurel, New Jersey

About this profile

What does Christina K. Theodorou inspect?

Christina K. Theodorou appears on 19 documents on file covering 16 sites, mostly in Pennsylvania.

What do they cite most often?

21 CFR 211.22 (responsibilities of quality control unit), followed by 21 CFR 211.42 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Christina K. Theodorou is dated May 27, 2026.